Back to companies
Starling Oncology, Inc.
STLNUSNASDAQPharmaceuticals & HealthcareStarling Oncology, Inc.
Revenue
$502.7mn
YoY +27.8%
Operating income
-$36.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API